CDC Trial Gel to Prevent HIV in Women
CDC reports promising results from CAPRISA microbicide trial showing tenofovir-based vaginal gel may help women prevent HIV infection and reduce genital herpes risk.
HIV research
CDC reports promising results from CAPRISA microbicide trial showing tenofovir-based vaginal gel may help women prevent HIV infection and reduce genital herpes risk.